DCT

2:23-cv-03531

Boehringer Ingelheim Pharma Inc v. Anobri Pharma US LLC

General
Filed
06/29/23
Cause of ActionPatent Infringement
SectorTransport., E-Comm.
StatusClosed
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
74%
Defendant
Party
Attorney